Phibro Animal Health (PAHC) Common Equity (2013 - 2026)

Phibro Animal Health has reported Common Equity for 14 years, with the latest figure at $385.5 million in Q2 2026.

• On a quarterly basis, Common Equity rose 34.93% year-over-year to $385.5 million in Q2 2026; TTM through Jun 2026 was $385.5 million, a 34.93% increase from a year earlier, with the FY2026 full-year figure at $385.5 million, up 34.93% from the prior year.
• Common Equity was $385.5 million for Q2 2026 at Phibro Animal Health, up from $361.8 million in the prior quarter.
• The five-year high for Common Equity was $385.5 million in Q2 2026, with the low at $246.8 million in Q4 2024.
• Average Common Equity over 5 years is $285.2 million, with a median of $270.4 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2026: Common Equity declined 9.16% in 2024, then surged 36.03% in 2026.
• Over 5 years, Common Equity stood at $268.4 million in 2022, then grew by 0.91% to $270.8 million in 2023, then decreased by 8.86% to $246.8 million in 2024, then jumped by 34.67% to $332.4 million in 2025, then climbed by 15.98% to $385.5 million in 2026.
• The last three Common Equity figures came in at $385.5 million (Q2 2026), $361.8 million (Q1 2026), and $332.4 million (Q4 2025), per Business Quant data.